Found 416 hits.
| 107 | Altrichter, S., Peter, H.-J., Pisarevskaja, D., Metz, M., Martus, P., and Maurer, M.+: IgE mediated autoallergy against thyroid peroxidase – a novel pathomechanism of chronic spontaneous urticaria? PLoS ONE 2011: 6; e14794. IF: 4.09 |
o.107
| 114 | Maurer, M.+ Altrichter, S., Bieber, T., Biedermann, T., Bräutigam, M., Seyfried, S, Brehler, R., Grabbe, J., Hunzelmann, N., Jakob, T., Jung, A., Kleine-Tebbe, J., Mempel, M., Meurer, M., Reich, K., Ruëff, F., Sengupta, K., Sieder, C., Simon, J. C., Wedi, B., Zuberbier, T., Mahler, V., and Staubach, P.: Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase. J. Allergy Clin. Immunol. 2011: 128; 202-209. IF: 11.00 |
o.114
| 278 | Caballero, T. + Aberer, W., Longhurst, H. J., Maurer, M. Zanichelli, A., Perrin, A., Bouillet, L., and Andresen, I.: The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries. J. Eur. Acad. Dermatol. Venereol. 2017: 31; 1214-1222. IF: 4.29 |
| 377 | Hawro, T., Hawro, M., Zalewska-Janowska, A., Weller, K., Metz, M., and Maurer M.+: Pruritus and sleep disturbances in patients with psoriasis. Arch. Dermat. Res. 2020: 312; 103-111. IF: 3.02 |
o.377
| 33 | Peters, E. M., Maurer, M. Botchkarev, V. A., deMasey Jensen, K., Welker, P., Scott, G. A., and Paus, R.+: Kit is expressed by epithelial cells in vivo. J. Invest. Dermatol. 2003: 121; 976-984. IF: 4.19 |
| 260 | Altrichter, S., Koch, K., Church, M. K., and Maurer, M.+: Atopic predisposition in cholinergic urticaria patients and its implications. J. Eur. Acad. Dermatol. Venereol. 2016: 30; 2060-2065. IF: 3.52 |
| 259 | Hawro, T., Lehmann, S., Altrichter, S., Fluhr, J. W., Zuberbier, T., Church, M. K., Maurer, M.+ and Metz, M.: Skin provocation tests may help to diagnose atopic dermatitis. Allergy 2016: 71; 1745-1752. IF: 7.36 |
| 433. | Cherrez-Ojeda, I.+, Vanegas, E., Cherrez, A., Felix, M., Weller, K., Magerl, M., Maurer, R. R., Mata, V. L., Kasperska-Zajac, A., Sikora, A., Fomina, D., Kovalkova, E., Godse, K., Rao, N. D., Khoshkhui, M., Rastgoo, S., Criado, R. F. J., Abuzakouk, M., Grandon, D., Van Doorn, M. B. A., Rodrigues Valle, S. O., Magalhaes, E., De Souza Lima, E. M., Thomsen, S. F., Ramón, G. D., Matos Benavides, E. E., Bauer, A., Giménez-Arnau, A. M., Kocatürk, E., Guillet, C., Larco, J. I., Zhao, Z. T., Makris, M., Ritchie, C., Xepapadaki, P., Ensina, L. F., Cherrez, S., and Maurer, M.: How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study. World Allergy Organ. J. 2021: 14; e100542. IF: 5.52 |
o.433
| 374 | Ertaş, R., Hawro, T., Altrichter, S., Özyurt, K., Erol, K., Ketenci Ertaş, S., and Maurer, M.+: Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU. Allergy 2020: 75; 468-470. IF: 13.15 |
o.374
|
475. |
Weller, K.+, Maurer, M., Bauer, A., Wedi, B., Wagner, N., Schliemann, S., Kramps, T., Baeumer, D., Multmeier, J., Hillmann, E., and Staubach, P.: Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany. J. Eur. Acad. Dermatol. Venereol. 2022: 36; 91-99. IF: 9.20 |
o.475